Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Evaluation of the Pharmacological Actions and Pharmacokinetics of BOF‐4272, a Xanthine Oxidase Inhibitor, in Mouse Liver
- S. Naito, M. Nishimura, Y. Tamao
- Chemistry, Medicine
- The Journal of pharmacy and pharmacology
- 1 February 2000
BOF‐4272 (±)‐8‐(3‐methoxy‐4‐phenylsulphinylphenyl) pyrazolo[1,5‐a]‐1,3,5‐triazine‐4‐(1H)‐one, a new synthetic anti‐hyperuricaemic drug, which has a chiral centre and exists as racemates, is a potent… Expand
Study of the enantioselective binding between BOF-4272 and serum albumins by means of high-performance frontal analysis.
- A. Shibukawa, M. Kadohara, J. He, M. Nishimura, S. Naito, T. Nakagawa
- Chemistry, Medicine
- Journal of chromatography. A
- 3 March 1995
High-performance frontal analysis (HPFA) was incorporated in an on-line HPLC system for the study of the enantioselective binding of BOF-4272, a new xanthine oxidase inhibitor, with human, bovine and… Expand
Hepatic local disposition of a drug with high protein binding and high hepatic clearance using BOF-4272 as a model drug.
- M. Nishimura, K. Yamaoka, S. Naito, T. Nakagawa
- Chemistry, Medicine
- Biological & pharmaceutical bulletin
- 15 September 1996
The local disposition of a drug, which is efficiently eliminated by the liver in spite of very high binding with serum albumin, was investigated using BOF-4272 as a model drug in the hepatic… Expand
Effect of temperature in perfusate on local hepatic disposition of BOF-4272, a new xanthine oxidase inhibitor.
- M. Nishimura, K. Yamaoka, H. Yasui, S. Naito, T. Nakagawa
- Chemistry, Medicine
- Biological & pharmaceutical bulletin
- 15 July 1995
The effect of temperature on the local hepatic disposition of BOF-4272 [(+/-)-8-(3-methoxy-4-phenylsulfinyl-phenyl)pyrazolo[1,5-a]-1,3,5- triazine-4-olate], a new drug used to treat hyperuricemia,… Expand
Influence of albumin on enantioselective local disposition of BOF-4272, a xanthine oxidase inhibitor with chiral sulfoxide, in rat liver.
- M. Nishimura, K. Yamaoka, S. Naito, T. Nakagawa
- Chemistry, Medicine
- Biological & pharmaceutical bulletin
- 15 December 1997
8-(3-Methoxy-4-phenylsulfinylphenyl) pyrazolo[1,5-a]-1,3,5-triazine-4(1H)-one (BOF-4272) blocks xanthine oxidase/xanthine dehydrogenase in the liver. BOF-4272 with a sulfoxide chiral center includes… Expand
Local disposition of a new xanthine oxidase/xanthine dehydrogenase inhibitor, BOF-4272, in rat liver.
- M. Nishimura, K. Yamaoka, H. Yasui, S. Naito, T. Nakagawa
- Chemistry, Medicine
- Biological & pharmaceutical bulletin
- 15 September 1994
The local hepatic disposition of BOF-4272, a newly developed xanthine oxidase (XO)/xanthine dehydrogenase (XDH) inhibitor, was evaluated in the rat perfusion system following pulse input of the drug… Expand
Studies on Metabolic Fate of Oxybutynin Hydrochloride (3) Metabolism in Human and Dog and The Site of Biotransfornation and the Effect on Enzymes Induction in the Rats
- Y. Shinozaki, R. Monden, +8 authors G. Urakubo
- Chemistry
- 1986
The metabolites, metabolizing organs of oxybutynin and its effect on the induction of drug metabolizing enzymes were investigated in rat, dog and human after oral administrations of oxybutynin and… Expand
Pharmacokinetics of BOF‐4272, a Xanthine Oxidase Inhibitor, after Single Intravenous or Oral Administration to Male Mice and Rats
- S. Naito, M. Nishimura, H. Nogawa
- Chemistry, Medicine
- The Journal of pharmacy and pharmacology
- 1 March 1999
BOF‐4272, (±)‐8‐(3‐methoxy‐4‐phenylsulphinylphenyl) pyrazolo [1,5‐a]‐1,3,5‐triazine‐4 (1H)‐one), is a new drug intended for the treatment of hyperuricaemia. This report describes the detailed… Expand
Metabolic pathways and pharmacokinetics of BOF-4272, a sulfoxide-containing drug, in the dog: in vivo and in vitro studies.
- S. Naito, M. Nishimura, H. Yoshitsugu, H. Nogawa
- Medicine, Chemistry
- Biological & pharmaceutical bulletin
- 15 December 1999
BOF-4272, (+/-)-8-(3-methoxy-4- phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5-triazine-4(1H)-one, is a new drug intended for the treatment of hyperuricemia. This report describes the detailed metabolic… Expand
Enantioselective uptake of BOF-4272, a xanthine oxidase inhibitor with a chiral sulfoxide, by isolated rat hepatocytes.
- S. Naito, M. Nishimura
- Chemistry, Medicine
- Yakugaku zasshi : Journal of the Pharmaceutical…
- 1 December 2001
The transport mechanisms of the enantiomers of BOF-4272, a new drug for the treatment of hyperuricemia, were studied using freshly prepared rat hepatocytes. BOF-4272 consists of S(-) and R(+)… Expand
...
1
2
...